Arginteanu M S, Byun H, King W
Department of Neurosurgery, Mount Sinai Medical Center, New York, New York, USA.
J Neurotrauma. 1999 Dec;16(12):1235-9. doi: 10.1089/neu.1999.16.1235.
Previous reports describe the intraventricular, subarachnoid, and intraparenchymal use of thrombolytic agents. However, the use of thrombolytic agents in the management of extraaxial hematomas has not been described. Following the evacuation of a subacute subdural hematoma, this 48-year-old woman experienced declining neurologic function due to the reaccumulation of blood in the subdural space. Urokinase was administered via a subdural drain. The patient experienced rapid clinical improvement and radiographic resolution of the recrudescent subdural hematoma. If repeat surgical evacuation of a subdural hematoma is not possible, urokinase may be instilled into the subdural space to enhance drainage of a subdural hematoma.
既往报告描述了溶栓剂在脑室内、蛛网膜下腔和脑实质内的应用。然而,尚未有关于溶栓剂用于治疗轴外血肿的报道。在清除亚急性硬膜下血肿后,这位48岁女性因硬膜下间隙再次积血而出现神经功能下降。通过硬膜下引流管给予尿激酶。患者临床症状迅速改善,复发性硬膜下血肿在影像学上也得到消退。如果无法再次进行硬膜下血肿手术清除,可将尿激酶注入硬膜下间隙以促进硬膜下血肿的引流。